🔗 Share this article

This year's prestigious award in Physiology or Medicine has been awarded for revolutionary findings that clarify how the body's defense network targets dangerous infections while sparing the healthy tissues.

A trio of renowned scientists—from Japan Shimon Sakaguchi and US experts Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research identified specialized "security guards" within the immune system that remove malfunctioning defense cells capable of harming the organism.

These discoveries are now enabling innovative therapies for immune disorders and malignancies.

These laureates will share a prize fund worth 11 million SEK.

Crucial Findings

"Their research has been essential for understanding how the body's defenses functions and why we do not all develop severe self-attack conditions," stated the head of the Nobel Committee.

The trio's research address a fundamental mystery: How does the immune system defend us from numerous invaders while leaving our own tissues intact?

The body's protection system employs immune cells that scan for signs of disease, even viruses and bacteria it has never encountered.

Such cells employ detectors—called recognition units—that are produced randomly in a vast number of combinations.

That provides the defense network the ability to combat a broad range of threats, but the unpredictability of the mechanism unavoidably creates white blood cells that can target the host.

Protectors of the Immune System

Researchers previously understood that some of these harmful white blood cells were destroyed in the immune organ—the site where immune cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to disarm any defenders that assault the healthy cells.

It is known that this mechanism malfunctions in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A Nobel panel added, "These findings have established a new field of research and spurred the creation of new therapies, for instance for tumors and immune disorders."

Regarding malignancies, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their numbers.

For autoimmune diseases, trials are exploring boosting T-reg cells so the body is no longer being harmed. A similar method could also be useful in reducing the chances of transplanted organ failure.

Pioneering Studies

Prof Shimon Sakaguchi, of Osaka University, performed tests on rodents that had their immune gland removed, leading to autoimmune disease.

The researcher showed that introducing defense cells from other animals could prevent the illness—suggesting there was a mechanism for blocking defenders from harming the host.

Mary Brunkow, affiliated with the Institute for Systems Biology in a US city, and Dr. Ramsdell, currently at a biotech firm in San Francisco, were investigating an genetic immune disorder in mice and people that led to the discovery of a gene critical for the way T-regs operate.

"The groundbreaking research has revealed how the immune system is controlled by regulatory T cells, preventing it from mistakenly targeting the healthy cells," commented a prominent physiology expert.

"This work is a remarkable illustration of how fundamental biological study can have far-reaching implications for human health."